Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Lokelma approved in China for the treatment of adult patients with hyperkalaemia

      FDA Approvals
      AstraZeneca’s Lokelma has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the blood). The approval by...

      Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization

      Drug Development
      The Syneos Health® Insights Hub, a dynamic destination for what’s next thinking and future-focused insights, released 2020 Health Trends: Changing Lives and Life Sciences....

      Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

      Manufacturing
      Merck known as MSD outside the United States and Canada, announced an exclusive worldwide research collaboration and license agreement with Taiho Pharmaceutical Co, Ltd.,...

      Cergentis launches TLA technology for complete cancer gene mutation sequencing

      Drug Development
      Cergentis, a genomics company that develops and commercialises kits and services based on its proprietary Targeted Locus Amplification (TLA) technology, announced the launch of...

      FedEx Express ships pharma goods for Japanese clinical trial

      Clinical Trials
      FedEx Express is supporting a clinical trial run by Life Science Center in Tokyo, Japan, by shipping pharma products to and from the Center...

      Dicerna, Novo Nordisk sign RNAi deal for liver-related cardio-metabolic diseases

      Drug Development
      US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs for liver-related cardio-metabolic diseases. In...

      Elsevier and FDA to work on AI algorithm for drug-induced liver injury

      FDA Approvals
      Elsevier is working with the National Center for Toxicological Research (NCTR) at the FDA on a predictive drug-induced liver injury (DILI) algorithm. The company...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.